This protocol is designed to detox from the #spike_protein amyloid after the #mRNA vaccine to avoid #long_Covid and to remove triggers for #autoimmune disease after vaccination.
1837 patients with different side effects post COVID mRNA vaccine or suffering from long Covid symptoms have and are using this protocol
Efficacy = 97%
Against: #Myocarditis, #pericarditis , #MS , #Billy's palsy , #insulin_resistance#vasculitis , and other autoimmune conditions
1. N-acetyle cysteine: 2000 mg daily
NAC works as antidote for amyloid spike protein and removes proteins produced from ORF3a embedded in cell surface.
2. Alpha-lipoic acid (ALA): 1000 mg daily
ALA play as anti cf-mtDNA ( cell free mitochondria DNA ) thence prevents immune system paralysis and autoimmunity
3. Lactoferrin 300 mg daily
Lactoferrin protects transferrin receptors and stop spike protein from being attached to with these receptor releasing unbound forms of iron-carrying hemoglobin which result in in kidney injury.
Protecting transferrin receptors will protect against anemia and the reduction of oxygen delivery to tissues. In addition, sustaining the body's ability to clear aged RBCs, as toxic levels of free iron can be released in cases of disease-associated RBC damage
5. Hawthorn leaf soaked this act as natural anti #NETosis that takes place in blood vessels as an #immune response resulting in coagulation and other circulatory conditions.
On the way to SUPERVARIANT
The following expectations are generated via bioinformatics regarding Omicron BA.2 sub variant and mutations to come with pathogenicity.
At present Omicron BA.2 spike protein have 03 new mutations (F486V, L452R, R493Q).
During the month of June 2022, the spike protein in Omicron BA.2 is expected to complete 28 mutations creating two (02) sub variants, namely: BA.4 and BA.5
The mutations creating the new 02 subvariants (BA.4 and BA.5)
are expected to take place in locations: 127 to 188, 644 to 735, 454 to 500 and 862 to 982
This gives a valid reason why new symptoms caused by infection will arise from June 2022 onwards.